Inhibrx Biosciences, Inc. · NASDAQ:INBX

Lappe Mark bought 10,000 Inhibrx Biosciences, Inc. shares (Form 4)

Traded Sep 25 to Sep 28, 2026 · Filed Sep 28, 2026

From Sep 25 to Sep 28, 2026, Lappe Mark (Director, Chief Executive Officer) bought 10,000 Inhibrx Biosciences, Inc. shares at an average US$99.88 for US$999K, leaving 740,548 shares. Filed Sep 28, 2026 (Form 4).

Bought: 10,000 shares
Price: US$99.88 average (US$98.87 to US$101.70)
Value: US$999K
Holding after: 740,548 shares (held indirectly)
Trading plan: No
Role: Director, Chief Executive Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Sep 25, 2026	Common Stock	Buy	3,324	US$98.87	733,872	Indirect
Sep 25, 2026	Common Stock	Buy	2,176	US$99.60	736,048	Indirect
Sep 28, 2026	Common Stock	Buy	1,500	US$98.88	737,548	Indirect
Sep 28, 2026	Common Stock	Buy	3,000	US$101.70	740,548	Indirect

Source

View original at SEC

Related